Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) has provided an update.
Jenscare Scientific Co., Ltd. has reported the voting results of its 2025 third extraordinary general meeting held in Ningbo, where shareholders representing about 69.6% of issued shares were present in person or by proxy. All four resolutions put forward were approved by poll, including amendments to the rules of procedure for shareholders’ general meetings and the board of directors, the abolition of the board of supervisors, and changes to the articles of association, with each resolution receiving 100% or near-unanimous support among votes cast. The outcome signals a significant overhaul of the company’s corporate governance structure, consolidating oversight within the board and updated articles, which may streamline decision-making and align the company’s governance framework more closely with Hong Kong listing requirements and evolving market practices, while indicating strong shareholder backing for the board’s strategic direction.
More about Jenscare Scientific Co. Ltd. Class H
Jenscare Scientific Co., Ltd. is a medical device company incorporated in the People’s Republic of China and listed in Hong Kong, with its H shares traded under stock code 9877. The company operates within China’s healthcare and life sciences sector, focusing on the development and commercialization of scientific and clinical technologies, and targets both domestic and international capital markets through its H-share structure.
Average Trading Volume: 609,897
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.18B
Learn more about 9877 stock on TipRanks’ Stock Analysis page.